Let’s look at the key reasons that are pushing Dynavax Technologies Corp (DVAX) to new highs

On Tuesday, Dynavax Technologies Corp (NASDAQ: DVAX) opened higher 0.46% from the last session, before settling in for the closing price of $12.94. Price fluctuations for DVAX have ranged from $9.74 to $13.89 over the past 52 weeks.

During the last 5-year period, the sales growth of Healthcare Sector giant was 217.13%. Company’s average yearly earnings per share was noted 507.80% at the time writing. With a float of $130.92 million, this company’s outstanding shares have now reached $131.34 million.

Let’s determine the extent of company efficiency that accounts for 408 employees. In terms of profitability, gross margin is 82.85%, operating margin of -3.42%, and the pretax margin is 9.29%.

Dynavax Technologies Corp (DVAX) Breakdown of a Key Holders of the stock

A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Dynavax Technologies Corp is 0.41%, while institutional ownership is 103.23%. The most recent insider transaction that took place on May 31 ’24, was worth 43,127. In this transaction Director of this company sold 3,615 shares at a rate of $11.93, taking the stock ownership to the 36,905 shares. Before that another transaction happened on Mar 01 ’24, when Company’s Chief Accounting Officer sold 20,526 for $12.78, making the entire transaction worth $262,322. This insider now owns 0 shares in total.

Dynavax Technologies Corp (DVAX) Recent Fiscal highlights

Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.01 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 507.80% per share during the next fiscal year.

Dynavax Technologies Corp (NASDAQ: DVAX) Trading Performance Indicators

Check out the current performance indicators for Dynavax Technologies Corp (DVAX). In the past quarter, the stock posted a quick ratio of 12.34. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.55. Likewise, its price to free cash flow for the trailing twelve months is 75.38.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.13, a number that is poised to hit 0.04 in the next quarter and is forecasted to reach 0.27 in one year’s time.

Technical Analysis of Dynavax Technologies Corp (DVAX)

Looking closely at Dynavax Technologies Corp (NASDAQ: DVAX), its last 5-days average volume was 1.37 million, which is a drop from its year-to-date volume of 1.81 million. As of the previous 9 days, the stock’s Stochastic %D was 68.93%. Additionally, its Average True Range was 0.37.

During the past 100 days, Dynavax Technologies Corp’s (DVAX) raw stochastic average was set at 76.39%, which indicates a significant increase from 71.75% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 22.61% in the past 14 days, which was lower than the 32.08% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $12.76, while its 200-day Moving Average is $11.69. However, in the short run, Dynavax Technologies Corp’s stock first resistance to watch stands at $13.14. Second resistance stands at $13.28. The third major resistance level sits at $13.49. If the price goes on to break the first support level at $12.79, it is likely to go to the next support level at $12.58. Now, if the price goes above the second support level, the third support stands at $12.44.

Dynavax Technologies Corp (NASDAQ: DVAX) Key Stats

There are currently 131,455K shares outstanding in the company with a market cap of 1.71 billion. Presently, the company’s annual sales total 232,280 K according to its annual income of -6,390 K. Last quarter, the company’s sales amounted to 80,630 K and its income totaled 17,590 K.